ARCHIVES

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

This article is from The Cancer Letter archive.

Vol. 05 No. 39 | September 28, 1979

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001

Upon, Panel Lean To Anecdotal Laetrile Study

August 12, 1977

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001